Genomic Health(美國(guó))

Genomic Health

美國(guó)GenomicHealthwww.genomichealth.com美國(guó)癌癥分子診斷市場(chǎng)第二大廠為GenomicHealth約占美國(guó)癌癥分子診斷市場(chǎng)27.7%，且?guī)缀跬耆珌?lái)自乳腺癌市場(chǎng)，它的OncotypeDXR.測(cè)試在早期乳腺癌病人中，能預(yù)測(cè)乳腺癌的續(xù)發(fā)可能性以及化療的效果，該公司以產(chǎn)品的差異化戰(zhàn)略取得了市場(chǎng)顯著的突破。GenomicHealth,alifesciencecompanyfou ndedinAugustof2000andlocatedinRedwoodCity,California,iscommittedtoimprovingthequalityofcancertreatmentdecisionsthroughtheresearch,developmentandcommercializationofgenomic-basedclinicallaboratoryservices.Tothatend,thecompanyconductssophisticatedgenomicresearchtodevelopclinically-validatedmoleculardiagnosticswhichprovideindividualizedinformationonresponsetocertaintypesoftherapy,aswellasthelikelihoodofdiseaserecurrence.Thesediagnostictechnologiesgenerateinformationthathealthcareprovidersandpatientscanuseinmakingtreatmentdecisions.ThepioneeringworkofGenomicHealthinmoleculardiagnosticshasledtotheOncotypeDXBreastCancerAssay,alaboratorytestthatanalyze